Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bosutinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC known ✓ | P12931 | 19/20 | 0.97 |
| ▸ | ABL1 known ✓ | P00519 | 5/20 | 0.97 |
| ▸ | BCR known ✓ | P11274 | 4/20 | 0.97 |
| ▸ | LYN known ✓ | P07948 | 1/20 | 0.97 |
| ▸ | HCK known ✓ | P08631 | 1/20 | 0.97 |
| ▸ | FYN | P06241 | 2/20 | 0.97 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.97 |
| ▸ | ABL2 | P42684 | 2/20 | 0.97 |
| ▸ | WEE2 | P0C1S8 | 2/20 | 0.97 |
| ▸ | WEE1 | P30291 | 2/20 | 0.97 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.97 |
| ▸ | STK25 | O00506 | 1/20 | 0.97 |
| ▸ | CIT | O14578 | 1/20 | 0.97 |
| ▸ | RIOK3 | O14730 | 1/20 | 0.97 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.97 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.97 |
| ▸ | CASK | O14936 | 1/20 | 0.97 |
| ▸ | GAK | O14976 | 1/20 | 0.97 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.97 |
| ▸ | MAP3K13 | O43283 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bosutinib SCHEMBL29350234 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL19207253 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL2887945 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL29389315 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL158390 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL29428159 | 0.98 | SRC (1.00) | SRCABL1BCRFYNKCNH2 | |
| Bosutinib SCHEMBL19207277 | 0.96 | SRC (0.92) | SRCABL1BCRFYNKCNH2 | |
| SCHEMBL30453343 | 0.94 | SRC (0.92) | SRCABL1BCRFYNKCNH2 | |
| SCHEMBL676669 | 0.94 | SRC (0.92) | SRCABL1BCRFYNKCNH2 | |
| SCHEMBL677073 | 0.94 | SRC (0.92) | SRCABL1BCRFYNKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017134679-A1 | NOVEL CRYSTALLINE POLYMORPHS OF 4-[(2.4-DICHIORO-5-METHOXVPHENVL)ANIINOL- 6-METHOXV-7-13-(4-METHYL-L-PIPERAZINVL)PROPOXVL-3-QUINOLINECARBONITRILE AND PROCESS FOR PREPARATION THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2017-08-10 | — | — | WO | disclosed |